Titlebook: High Density Lipoproteins; From Biological Unde Arnold von Eckardstein,Dimitris Kardassis Book‘‘‘‘‘‘‘‘ 2015 The Editor(s) (if applicable) a

CHECK

Regulation of HDL Genes: Transcriptional, Posttranscriptional, and Posttranslationalction cascades; regulation at the posttranscriptional level by microRNAs and other noncoding RNAs which bind to the coding or noncoding regions of HDL genes regulating mRNA stability and translation; as well as regulation at the posttranslational level by protein modifications, intracellular traffic

隱語

Accrue

concubine

Inscrutable

Epidemiology: Disease Associations and Modulators of HDL-Related Biomarkersse. In addition, a low level of HDL-C has been shown to be a risk factor for other diseases not related to atherosclerosis. However, recent studies have not supported a causal effect of HDL-C in the development of atherosclerosis. Furthermore, new drugs markedly elevating HDL-C levels have been disa

Expressly

FECT

平息

Dysfunctional HDL: From Structure-Function-Relationships to Biomarkersies. However, recent clinical trials on lipid-modifying drugs that increase plasma levels of HDL-C have not shown significant clinical benefit. Notably, in some recent clinical studies, there is no clear association of higher HDL-C levels with a reduced risk of cardiovascular events observed in pati

Constant

HDL and Atherothrombotic Vascular Diseaseeven facilitate lesion regression. These activities include promoting cellular cholesterol efflux, protecting low-density lipoproteins (LDLs) from modification, preserving endothelial function, as well as anti-inflammatory and antithrombotic effects. However, questions remain about the relative impo

LATER

HDLs, Diabetes, and Metabolic Syndromeassociated with significant morbidity and mortality, in particular with an excess of cardiovascular deaths. Type 2 diabetes mellitus and the cluster of pathologies including insulin resistance, central obesity, high blood pressure, and hypertriglyceridemia that constitute the metabolic syndrome are